ArticleBMC pediatrics2026
Clinical efficacy of single-port transscrotal laparoscopic orchiopexy combined with hernia needle for palpable undescended testes in children.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the clinical efficacy and safety of single-port transscrotal laparoscopic orchiopexy combined with a hernia needle (SPLT-Orchiopexy) in children with palpable middle- and low-position undescended testes.
methodsA retrospective analysis was conducted on 200 children with palpable middle- and low-position undescended testes who underwent surgical treatment at our hospital between March 2021 and April 2023. Patients were categorized into two groups according to the surgical technique used: the conventional laparoscopic surgery (CLS, n = 120) group and the SP-Orchiopexy group (n = 80). Perioperative indicators, postoperative pain assessed using the Face, Legs, Activity, Cry, and Consolability (FLACC) scale. Scar outcomes at 6 months postoperatively were evaluated using the Observer Scar Assessment Scale (OSAS) and the Patient Scar Assessment Scale (PSAS), which were compared between two groups. The incidence of postoperative complications was also compared between groups. Logistic regression analysis was performed to identify factors associated with postoperative complications.
resultsThe SPLT-Orchiopexy group showed significantly shorter operative time, less intraoperative blood loss, earlier ambulation, and shorter length of hospital stay (t = 11.15-16.91, all P < 0.001). FLACC scores at 6, 12, and 24 h postoperatively were significantly lower in the SPLT-Orchiopexy group (Z = 4.67-6.91, all P < 0.001). At 6-month follow-up, both OSAS and PSAS scores were lower in the SPLT-Orchiopexy group (Z/t = 7.31-7.65, all P < 0.001). The overall incidence of postoperative complications was lower in the SPLT-Orchiopexy group (χ² = 4.68, P = 0.031). The surgical approach did not reach statistical significance as an independent predictor of postoperative complications, but it demonstrated a trend toward reduced complication risk (Wald = 1.49, P = 0.222).
conclusionSPLT-Orchiopexy may provide advantages in terms of minimal invasiveness, postoperative recovery, pain relief, cosmetic outcomes, and postoperative complications in children with palpable middle- and low-position undescended testes. Further prospective studies are warranted to validate these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.